Fundraising Fox
シンクサイト
Redwood City, US · Founded 2016 · 49 employees on LinkedIn · 5 known investors
Find your way into シンクサイト
Sign up to see every warm intro you have to シンクサイト
- Paths you didn't know you had: your email and LinkedIn already hold routes to the シンクサイト team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ThinkCyte develops diagnostic devices and cellular analysis platforms using imaging flow cytometry and microfluidics technology. The company serves research institutions, clinical laboratories, and biopharmaceutical companies in the life sciences and diagnostic tools sector.
Founders & leadership
シンクサイト was founded in 2016 by Waichiro, Sadao, Issei, and Ryoichi.
W
WaichiroCo-founder & CEO
S
SadaoCo-founder & CSO
I
IsseiCo-founder & Senior Scientific Advisor
R
RyoichiCo-founder
Investors · 5
Berkeley SkyDeck Fundlisted by Berkeley SkyDeck FundBerkeley · $200K
How we know: Berkeley SkyDeck Fund's portfolio page · Not right? Tell us
Global Brainlisted by Global BrainTokyo · $100K
How we know: Global Brain's portfolio page · Not right? Tell us
Related companies · 6
Incyte CorporationIncyte is a biopharmaceutical company that develops and commercializes medicines for oncology, hematology, dermatology, and other therapeutic areas. The company focuses on bringing treatments to patients across multiple disease categories.
Rarecyte
Kite PharmaKite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.
Cellular IntelligenceCellular Intelligence develops cell therapy treatments, specifically acquiring STEM-PD, a Phase 2-ready therapy for Parkinson's disease. The company focuses on cell fate engineering to design biological solutions for neurological diseases.
jCytejCyte is a clinical-stage biotechnology company developing jCell, an investigational cell-based therapy for retinitis pigmentosa and other inherited retinal and blinding diseases. It is advancing multiple drug development programs targeting degenerative retinal disorders and optic nerve conditions to preserve and restore vision.
AgilentAgilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors. The company operates through three segments: Life Sciences and Diagnostics Markets (which includes contract manufacturing services for oligonucleotide therapeutics and pathology solutions), Agilent CrossLab (providing lab services and automation), and Applied Markets (offering analytical instruments and software).
Companies working in the same space as シンクサイト.
Frequently asked questions
- What does シンクサイト do?
- ThinkCyte develops diagnostic devices and cellular analysis platforms using imaging flow cytometry and microfluidics technology. The company serves research institutions, clinical laboratories, and biopharmaceutical companies in the life sciences and diagnostic tools sector.
- Who founded シンクサイト?
- シンクサイト was founded by Waichiro, Sadao, Issei, Ryoichi in 2016.
- Who are シンクサイト's investors?
- シンクサイト's investors include Berkeley SkyDeck Fund, Global Brain, Mitsui Sumitomo Insurance Capital, OSAKA University Venture Capital, UntroD Capital.
- Where is シンクサイト headquartered?
- シンクサイト is headquartered in Redwood City, US.